Fatty Liver Disease
Are You at Risk for Non-alcoholic, Fatty Liver Disease?
Currently, no drugs are globally approved for the treatment of Non-Alcoholic Steatohepatitis (NASH). First-line treatment is lifestyle intervention to achieve weight loss and treatment of other co-existing conditions like high blood pressure and diabetes. But other effective treatments for patients with NASH are needed.
That’s why Tandem Clinical Research is looking for volunteers with NASH for a research study of an investigational medication. To qualify, you must:
- Be 18 to 70 years of age
- Have a diagnosis of NASH
Early signs may include the following:
- Weight Loss
- Web-like clusters of blood vessels under your skin
- Itchy Skin
- Yellow skin and eyes
- Loss of appetite
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below today!
Liver Disease Research Study Form